News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3127last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
The Wall Street Journal57d agobearish
J&J Is In Talks to Sell Its Hips-and-Knees Business to Apollo for $20 BillionInvestor's Business Daily60d agoneutral
IPO Stock LB Pharma Has Tripled In Under A Year. Is It A Takeover Target?24/7 Wall St.69d agoneutral
Two Recessions Couldn’t Stop These 4 Healthcare Stocks From Raising Dividends24/7 Wall St.80d agoneutral
Why Bristol Myers, Johnson & Johnson and More Are Watching Seaport After IPOSimply Wall St.86d agoneutral
Johnson & Johnson (JNJ) Stock Looks Cheap On Cash Flow But Rich On EarningsBioPharma Dive86d agobullish
Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from Celgene24/7 Wall St.89d agobullish
Legend Biotech Gains 6% on Q2 Earnings Beat as Adjusted EPS Doubles Consensus